Emerging Markets Report: Five Golden Reasons
ORLANDO, Fla., Feb. 11, 2020 (GLOBE NEWSWIRE) — Often overshadowed by one of the best performing stock markets in recent […]
Martin Marietta Reports Fourth-Quarter and Full-Year 2019 Results
2019 Shipments and Pricing Improved for Aggregates, Cement and AsphaltFull-Year Consolidated Gross Margin Expanded 210 Basis Points2020 Outlook Reflects Continuing […]
ORYX Gaming Steps Up Gamification with New Player Engagement Platform
TORONTO, Feb. 11, 2020 (GLOBE NEWSWIRE) — ORYX Gaming, a Bragg Gaming Group company (TSXV: BRAG, OTC: BRGGF), has unveiled […]
Zomedica Files U.S. Patent Application for Fecal Parasite Detection
ANN ARBOR, Mich., Feb. 11, 2020 (GLOBE NEWSWIRE) — Zomedica Pharmaceuticals Corp. (NYSE American: ZOM)(“Zomedica” or “Company”), a veterinary diagnostic […]
Comstock Mining Provides Strategic Updates; MCU Secures Major International Remediation Project; Opportunity Fund Strategic Acquisitions
VIRGINIA CITY, Nev., Feb. 11, 2020 (GLOBE NEWSWIRE) — Comstock Mining Inc. (“Comstock” or the “Company”) (NYSE American: LODE) today […]
Monterey Minerals Signs LOI to Acquire the Alicia Project in the Philippines
TORONTO, Feb. 11, 2020 (GLOBE NEWSWIRE) — Monterey Minerals Inc. (the “Company” or “Monterey”) (CSE: MREY and FSE: 2DK) is […]
TSX News -
Centerra Gold Exceeds 2019 Gold Production Guidance Producing 783,308 Ounces and Announces 2020 Outlook including Öksüt Mine Production
This news release contains forward-looking information that is subject to assumptions and risk factors set out under the headings “Material […]
TSX News -
Kerr Mines Announces CDN$2.5 Million Private Placement
TORONTO, Feb. 11, 2020 (GLOBE NEWSWIRE) — Kerr Mines Inc. (TSX: KER, OTC: KERMF), (“Kerr” or the “Company”), announces that […]
TSX News -
ProMIS Neurosciences to Participate in Noble Capital Markets 16th Annual Investor Conference
TORONTO and CAMBRIDGE, Mass, Feb. 11, 2020 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company […]
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen® for Use Against the SARS-like Wuhan 2019 Novel Coronavirus
Ampligen® obtained 100% survival rate at clinically achievable human dosage levels for SARS in animal experimentsAmpligen key to proposed broad-spectrum ‘universal’ […]
